A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.
about
Genetically engineered mouse models of prostate cancerModeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.
P2860
A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@ast
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@en
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@nl
type
label
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@ast
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@en
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@nl
prefLabel
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@ast
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@en
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@nl
P2093
P2860
P356
P1433
P1476
A Hoxb13-driven reverse tetrac ...... ne expression in the prostate.
@en
P2093
Aminah Wali
Charles J Bieberich
Helya Ghaffari
Jamie C Heard
Laura N Mutton
Varsha Rao
P2860
P304
P356
10.1002/PROS.22490
P577
2012-02-01T00:00:00Z